These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27320587)

  • 1. Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients.
    Asavakarn S; Sirivatanauksorn Y; Promraj R; Ruenrom A; Limsrichamrern S; Kositamongkol P; Mahawithitwong P; Tovikkai C; Dumronggittigule W
    Transplant Proc; 2016 May; 48(4):1202-7. PubMed ID: 27320587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive Medication Adherence in Liver Transplant Recipients.
    Promraj R; Dumronggittigule W; Sirivatanauksorn Y; Ruenrom A; Tovikkai C; Limsrichamrern S; Kositamongkol P; Mahawithitwong P; Asavakarn S
    Transplant Proc; 2016 May; 48(4):1198-201. PubMed ID: 27320586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. University of Modena experience in HIV-positive patients undergoing liver transplantation.
    Di Benedetto F; Tarantino G; De Ruvo N; Cautero N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; Serra V; Rompianesi G; D'Amico G; Mimmo A; Iemmolo RM; Codeluppi M; Cocchi S; Guaraldi G; Gerunda GE
    Transplant Proc; 2011 May; 43(4):1114-8. PubMed ID: 21620066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study.
    Joost R; Dörje F; Schwitulla J; Eckardt KU; Hugo C
    Nephrol Dial Transplant; 2014 Aug; 29(8):1597-607. PubMed ID: 24914089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort.
    Gastaca M; Valdivieso A; Bustamante J; Fernández JR; Ruiz P; Ventoso A; Testillano M; Palomares I; Salvador P; Prieto M; Montejo M; Suárez MJ; de Urbina JO
    Liver Transpl; 2016 Oct; 22(10):1391-400. PubMed ID: 27434676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
    Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
    Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
    Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus plus mycophenolate mofetil as initial immunosuppression in liver transplantation.
    Jiménez-Pérez M; González Grande R; Rando Muñoz FJ; de la Cruz Lombardo J; Muñoz Suárez MA; Fernández Aguilar JL; Pérez Daga JA; Santoyo-Santoyo J; Manteca González R; Rodrigo López JM
    Transplant Proc; 2015; 47(1):90-2. PubMed ID: 25645779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial.
    Garcia MF; Bravin AM; Garcia PD; Contti MM; Nga HS; Takase HM; de Andrade LG
    Int Urol Nephrol; 2015 Nov; 47(11):1899-905. PubMed ID: 26377496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
    Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
    Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
    Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single center.
    Hu AB; Wu LW; Tai Q; Zhu XF; He XS
    J Dig Dis; 2013 Jan; 14(1):38-44. PubMed ID: 23134408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.
    Covert KL; Mardis CR; Fleming JN; Pilch NA; Meadows HB; Mardis BA; Mohan P; Posadas-Salas M; Srinivas T; Taber DJ
    Pharmacotherapy; 2017 Feb; 37(2):159-169. PubMed ID: 27997676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing specialty medication services through a specialty pharmacy program: the case of oral renal transplant immunosuppressant medications.
    Tschida S; Aslam S; Khan TT; Sahli B; Shrank WH; Lal LS
    J Manag Care Pharm; 2013; 19(1):26-41. PubMed ID: 23383705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of chronic rejection after treatment failure with FK506 and RS61443.
    Roberts JP; Lake JR; Hebert M; Nikolai B; Ascher NL; Ferrell LD
    Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression Strategies in the Treatment of Hepatocellular Carcinoma in Virgen de las Nieves University Hospital.
    San Miguel C; Fundora Y; Triguero J; Muffak K; Villegas T; Becerra A; Garrote D; Ferrón JA
    Transplant Proc; 2015 Oct; 47(8):2371-3. PubMed ID: 26518930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.